Preclinical
|
KRAS (KRAS proto-oncogene GTPase) • ALK (Anaplastic lymphoma kinase) • AKT1S1 (AKT1 Substrate 1)
|
BRAF V600E • KRAS mutation • KRAS G12C • BRAF V600 • ALK rearrangement • KRAS G12
|
Erbitux (cetuximab) • Vectibix (panitumumab) • Lumakras (sotorasib) • Braftovi (encorafenib) • IN01